UltraTech Cement EBITDA up 21%: FY27 raise, TP Rs 13,000

What UltraTech Cement reported this quarter

UltraTech Cement (UTCEM) reported consolidated EBITDA of Rs 56 bn, up 21% year-on-year and 43% quarter-on-quarter, and described as largely in line with estimates. The update comes at a time when brokerages are leaning on companies with visible operating levers and scale advantages. In commentary shared alongside the result note, analysts positioned UltraTech as a relatively stable pick in a volatile market environment. The focus remained on execution, cost savings and the company’s ability to strengthen its market-share position. The broader narrative also links UltraTech to India’s infrastructure-led demand outlook, where large producers tend to benefit from steady utilisation and pricing discipline.

EBITDA performance: the key number investors tracked

EBITDA of Rs 56 bn was the headline, with the growth split explicitly stated as 21% YoY and 43% QoQ. While the note does not provide revenue for the same period, the emphasis on EBITDA suggests profitability and cost management were central to the quarter’s read-through. The brokerage commentary also indicates the result was “largely in line” with its estimate, implying limited surprise on reported profitability versus expectations. In such quarters, markets typically shift attention from the print to forward guidance and management’s tone on demand and costs.

Why the quarter mattered beyond the headline print

Beyond the reported EBITDA, the note highlighted UltraTech as a preferred play on infrastructure-linked demand. It also reiterated confidence in the company’s ability to deliver cost savings and consolidate or strengthen its market-share position. This matters because, in cement, small changes in costs per tonne and regional mix can materially shift margins. UltraTech’s scale also makes it a key beneficiary when consolidation improves pricing discipline. The commentary did not cite new volume numbers, but it referenced “balanced guidance on cost, volume, etc,” indicating management’s outlook was not one-sided and considered multiple operating variables.

Outlook changes: FY27E EBITDA raised, FY28 broadly maintained

The brokerage raised its FY27E EBITDA estimate by about 11%, explicitly attributing this to balanced guidance on costs, volumes and related factors. It broadly maintained its FY28 estimates, suggesting the larger change was concentrated in FY27 rather than a multi-year reset. Importantly, the valuation framework was not changed in this note: UltraTech continues to be valued at 18x Mar-28E EV/EBITDA. The target price (TP) was kept unchanged at Rs 13,000, with the rating maintained at BUY.

Valuation stance: 18x Mar-28E EV/EBITDA, TP unchanged

UltraTech’s unchanged valuation multiple and TP suggest the brokerage sees the upgraded FY27E EBITDA as a support factor within its existing framework, rather than a trigger for re-rating assumptions. The note maintained 18x Mar-28E EV/EBITDA and reiterated the Rs 13,000 TP. In practical terms, that keeps the investment call tied to delivery on operating efficiencies and demand stability rather than a change in valuation assumptions. The BUY stance also aligns with multiple external broker notes and target prices listed in the provided data set.

Cost savings and operational levers cited by brokerages

Separate brokerage notes included in the provided text pointed to structural cost improvement as a core part of the UltraTech thesis. One note stated UltraTech has levers for structural cost improvement of INR 200-300 per tonne over the next three years. Another highlighted a commitment to deliver more than Rs 300 per tonne of operational cost rationalisation, with Rs 86 per tonne already achieved in FY25. Emkay Global’s note also referenced guidance of EBITDA per tonne of Rs 800 by FY27 for India Cements as part of the broader integration and turnaround expectations discussed in the context of consolidation.

India Cements transaction: stake increase, price, and approvals

The board of UltraTech Cement approved the acquisition of a 33% additional stake in India Cements Ltd from its promoters and associates at Rs 390 per share. The transaction was described at an enterprise value of $121 per tonne and an outflow of Rs 190 bn, subject to regulatory approvals. The text also recalled that UltraTech had acquired a 23% stake in India Cements in June, taking its total stake to 56% at an EV of $108 per tonne. In addition, UltraTech has made an open offer for a further 26% equity stake at Rs 390 per share. These steps were framed by Emkay Global as strengthening UltraTech’s position, particularly in the South.

Market-share and capacity commentary linked to consolidation

Broker commentary in the provided material stated that UltraTech’s capacity market share in the South could more than double to 25% by FY27E. It also said UltraTech India’s grey cement capacity is likely to cross 200 mt by FY27E, implying a 12% CAGR. The same set of notes argued consolidation can inject price discipline and support better profitability and return ratios over time. While these are brokerage views rather than reported results, they provide context for why consolidation and regional scale were highlighted alongside the quarterly EBITDA print.

Stock context: recent price level and technical markers shared

The provided text included a price reference of Rs 12,010 for the stock. It also listed nearby resistance levels: R2 at 12,372.68 and R3 at 12,530.41. A one-day technical snapshot categorised the stock as having more “Bullish” readings (10) than “Neutral” (2) and “Bearish” (1). Separately, another brokerage summary in Hindi stated UltraTech’s target price of Rs 13,000 implies around 13% potential upside from the recent share price, and that the stock was broadly flat on a year-on-year basis.

Key factual snapshot (as provided)

Broker recommendations table (selected entries from provided list)

What to watch next

The immediate signposts remain execution on cost controls, demand stability, and progress on consolidation-led strategy. On the modelling side, the FY27E EBITDA upgrade and unchanged FY28 view indicate attention will likely shift to delivery against the updated FY27 assumptions. For the India Cements transaction, the stated condition is regulatory approvals, alongside the open offer process already announced at Rs 390 per share. Any disclosures around timelines, integration milestones, or regional market-share movement would be the next data points investors track.